David Steensma MD, FACPOncologist, David P Steensma LLC, Cambridge, Massachusetts
Dr. Steensma was most recently the Global Head of Hematology for the Novartis Institutes of BioMedical Research (NIBR), leading early development across hematology programs. Prior to joining NIBR, he was the Edward P. Evans Chair in MDS and director of the Center for Prevention of Progression at Dana-Farber Cancer Institute in Boston.
Former employment, Novartis
Minor equity: Bluebird, Arrowhead, Gilead, TwoSeventy, GamidaCell